Jasmina I. Ivanova

531 total citations
17 papers, 422 citations indexed

About

Jasmina I. Ivanova is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Pharmacology. According to data from OpenAlex, Jasmina I. Ivanova has authored 17 papers receiving a total of 422 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 4 papers in Pharmacology. Recurrent topics in Jasmina I. Ivanova's work include Health Systems, Economic Evaluations, Quality of Life (4 papers), Colorectal Cancer Treatments and Studies (4 papers) and Gastric Cancer Management and Outcomes (4 papers). Jasmina I. Ivanova is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (4 papers), Colorectal Cancer Treatments and Studies (4 papers) and Gastric Cancer Management and Outcomes (4 papers). Jasmina I. Ivanova collaborates with scholars based in United States, United Kingdom and France. Jasmina I. Ivanova's co-authors include Howard G. Birnbaum, Evan Kantor, Ralph Swindle, M. Schiller, Bryan M. Johnstone, Matthew Davis, Amy Phillips, Dennis Meletiche, Pierre Y. Crémieux and Astra M. Liepa and has published in prestigious journals such as Journal of Clinical Oncology, CHEST Journal and Journal of Pain.

In The Last Decade

Jasmina I. Ivanova

15 papers receiving 407 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jasmina I. Ivanova United States 8 219 190 80 79 68 17 422
Ralph F. Staerkle Switzerland 13 351 1.6× 250 1.3× 93 1.2× 51 0.6× 409 6.0× 45 755
Karin Verkerk Netherlands 11 272 1.2× 173 0.9× 69 0.9× 65 0.8× 187 2.8× 16 528
Rolf Riise Norway 8 364 1.7× 324 1.7× 33 0.4× 30 0.4× 282 4.1× 8 583
John R. York Australia 6 301 1.4× 170 0.9× 35 0.4× 54 0.7× 80 1.2× 11 396
Elena Tseli Sweden 7 157 0.7× 34 0.2× 29 0.4× 34 0.4× 48 0.7× 12 339
Guus A. Meerhoff Netherlands 8 212 1.0× 67 0.4× 69 0.9× 34 0.4× 82 1.2× 10 371
Robert Winkelman United States 14 64 0.3× 195 1.0× 75 0.9× 20 0.3× 164 2.4× 38 548
Anna K. Wright United States 10 170 0.8× 151 0.8× 51 0.6× 19 0.2× 153 2.3× 19 339
Marie Jakobsen Denmark 9 68 0.3× 58 0.3× 33 0.4× 21 0.3× 52 0.8× 16 263
Paul N. Grooff United States 7 229 1.0× 209 1.1× 17 0.2× 32 0.4× 144 2.1× 9 400

Countries citing papers authored by Jasmina I. Ivanova

Since Specialization
Citations

This map shows the geographic impact of Jasmina I. Ivanova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jasmina I. Ivanova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jasmina I. Ivanova more than expected).

Fields of papers citing papers by Jasmina I. Ivanova

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jasmina I. Ivanova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jasmina I. Ivanova. The network helps show where Jasmina I. Ivanova may publish in the future.

Co-authorship network of co-authors of Jasmina I. Ivanova

This figure shows the co-authorship network connecting the top 25 collaborators of Jasmina I. Ivanova. A scholar is included among the top collaborators of Jasmina I. Ivanova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jasmina I. Ivanova. Jasmina I. Ivanova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Tjulandin, Sergei, A. Tryakin, Jasmina I. Ivanova, et al.. (2019). Real-world treatment patterns among patients with advanced gastric cancer in Russia: a chart review study. PubMed. 8(1). 150–158.
2.
Ivanova, Jasmina I., Jennifer Sung, Mei Sheng Duh, et al.. (2017). Real-world treatment patterns and effectiveness among patients with metastatic colorectal cancer treated with ziv-aflibercept in community oncology practices in the USA. Medical Oncology. 34(12). 193–193. 19 indexed citations
3.
Hess, Lisa M., Jasmina I. Ivanova, Xinyue Liu, et al.. (2017). Oncologist preferences in advanced soft tissue sarcoma: A discrete choice experiment.. Journal of Clinical Oncology. 35(8_suppl). 147–147.
4.
Carter, Gebra Cuyún, Anna Kaltenboeck, Jasmina I. Ivanova, et al.. (2016). Treatment patterns in patients with advanced gastric cancer in Taiwan. Asia-Pacific Journal of Clinical Oncology. 13(3). 185–194. 11 indexed citations
5.
Carter, Gebra Cuyún, Anna Kaltenboeck, Jasmina I. Ivanova, et al.. (2016). Real-World Treatment Patterns among Patients with Advanced Gastric Cancer in South Korea. Cancer Research and Treatment. 49(3). 578–587. 21 indexed citations
6.
Ivanova, Jasmina I., Howard G. Birnbaum, Evan Kantor, M. Schiller, & Ralph Swindle. (2014). Duloxetine Use in Employees with Low Back Pain: Treatment Patterns and Direct and Indirect Costs. Pain Medicine. 15(6). 1015–1026. 2 indexed citations
7.
8.
Ivanova, Jasmina I., Howard G. Birnbaum, M. Schiller, et al.. (2011). Real-world practice patterns, health-care utilization, and costs in patients with low back pain: the long road to guideline-concordant care. The Spine Journal. 11(7). 622–632. 252 indexed citations
9.
Kirson, Noam Y., et al.. (2010). Chronic Thromboembolic Pulmonary Hypertension (CTEPH): Direct Cost of Illness in the US Privately Insured Population. CHEST Journal. 138(4). 375A–375A. 2 indexed citations
10.
Ivanova, Jasmina I., et al.. (2010). Physiciansʼ Decisions to Prescribe Antidepressant Therapy in Older Patients with Depression in a US Managed Care Plan. Drugs & Aging. 28(1). 51–62. 9 indexed citations
11.
Kirson, Noam Y., Jasmina I. Ivanova, Howard G. Birnbaum, et al.. (2010). Comparing healthcare costs of Medicaid patients with postherpetic neuralgia (PHN) treated with lidocaine patch 5% versus gabapentin or pregabalin. Journal of Medical Economics. 13(3). 482–491. 7 indexed citations
12.
Kirson, Noam Y., Jasmina I. Ivanova, Howard G. Birnbaum, et al.. (2010). Descriptive analysis of Medicaid patients with postherpetic neuralgia treated with lidocaine patch 5%. Journal of Medical Economics. 13(3). 472–481. 4 indexed citations
13.
Ivanova, Jasmina I., et al.. (2009). The Cost of Disability and Medically Related Absenteeism Among Employees with Multiple Sclerosis in the US. PharmacoEconomics. 27(8). 681–691. 61 indexed citations
14.
Birnbaum, Howard G., Jasmina I. Ivanova, Matthew Davis, et al.. (2009). Economic impact of multiple sclerosis disease-modifying drugs in an employed population: direct and indirect costs. Current Medical Research and Opinion. 25(4). 869–877. 27 indexed citations
15.
Swindle, Ralph, et al.. (2009). Real-world practice patterns and costs in patients with low back pain. Journal of Pain. 10(4). S54–S54. 1 indexed citations
16.
Swindle, Ralph, Howard G. Birnbaum, Jasmina I. Ivanova, et al.. (2009). Real-world predictors of surgery in patients with low back pain: a CHAID analysis. Journal of Pain. 10(4). S55–S55. 1 indexed citations
17.
Birnbaum, HG, Jasmina I. Ivanova, Yohanne Kidolezi, & Sue Caleo. (2008). PND11 EPILEPSY COST OF ILLNESS IN THE U.S. PRIVATELY INSURED. Value in Health. 11(6). A602–A603. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026